75701-2025 - Contract modification
Spain – Pharmaceutical products – Suministro Gefitinib(DOE), Tenofovir disoproxilo (DOE), Carmustina (DOE) Parenteral, Deferasirox(DOE), Amoxicilina/Ácido Clavulánico (DOE) Parenteral y Asociacion Formoterol/Budesonida (DOE)
OJ S 24/2025 04/02/2025
Contract modification notice
Supplies
1. Buyer
1.1.
Buyer
Official name: OSAKIDETZA - Servicio Vasco de Salud - Organización Central
Email: contrata@osakidetza.eus
2. Procedure
2.1.
Procedure
Title: Suministro Gefitinib(DOE), Tenofovir disoproxilo (DOE), Carmustina (DOE) Parenteral, Deferasirox(DOE), Amoxicilina/Ácido Clavulánico (DOE) Parenteral y Asociacion Formoterol/Budesonida (DOE)
Description: Suministro Gefitinib(DOE), Tenofovir disoproxilo (DOE), Carmustina (DOE) Parenteral, Deferasirox(DOE), Amoxicilina/Ácido Clavulánico (DOE) Parenteral y Asociacion Formoterol/Budesonida (DOE)
Procedure identifier: f18e3014-945c-4531-be30-e33113c70a08
Internal identifier: 2022/01932
2.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33600000 Pharmaceutical products
2.1.2.
Place of performance
Country subdivision (NUTS): Araba/Álava (ES211)
2.1.2.
Place of performance
Country subdivision (NUTS): Gipuzkoa (ES212)
2.1.2.
Place of performance
Country subdivision (NUTS): Bizkaia (ES213)
2.1.4.
General information
Legal basis: 
Directive 2014/24/EU
5. Lot
5.1.
Lot: LOT-0001
Title: 1 - GEFITINIB (DOE)
Description: GEFITINIB (DOE)
Internal identifier: 1 - GEFITINIB (DOE)
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33600000 Pharmaceutical products
5.1.2.
Place of performance
Country subdivision (NUTS): Araba/Álava (ES211)
5.1.2.
Place of performance
Country subdivision (NUTS): Gipuzkoa (ES212)
5.1.2.
Place of performance
Country subdivision (NUTS): Bizkaia (ES213)
5.1.3.
Estimated duration
Duration: 1 Year
5.1.4.
Renewal
Maximum renewals: 0
5.1.6.
General information
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): yes
5.1.12.
Terms of procurement
Terms of contract: 
The execution of the contract must be performed within the framework of sheltered employment programmes: No
Electronic invoicing: Required
Electronic ordering will be used: no
Electronic payment will be used: no
5.1.16.
Further information, mediation and review
Review organisation: Órgano Administrativo de Recursos Contractuales de la Comunidad Autónoma de Euskadi
Information about review deadlines: Se iniciará mediante escrito que deberá presentarse en el plazo de 15 días hábiles. Dicho plazo se computará conforme a la Ley de Contratos del Sector Público.
Organisation providing additional information about the procurement procedure: OSAKIDETZA - Servicio Vasco de Salud - Organización Central
5.1.
Lot: LOT-0002
Title: 2 - TENOFOVIR DISOPROXILO (DOE)
Description: TENOFOVIR DISOPROXILO (DOE)
Internal identifier: 2 - TENOFOVIR DISOPROXILO (DOE)
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33600000 Pharmaceutical products
5.1.2.
Place of performance
Country subdivision (NUTS): Araba/Álava (ES211)
5.1.2.
Place of performance
Country subdivision (NUTS): Gipuzkoa (ES212)
5.1.2.
Place of performance
Country subdivision (NUTS): Bizkaia (ES213)
5.1.3.
Estimated duration
Duration: 1 Year
5.1.4.
Renewal
Maximum renewals: 0
5.1.6.
General information
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): yes
5.1.12.
Terms of procurement
Terms of contract: 
The execution of the contract must be performed within the framework of sheltered employment programmes: No
Electronic invoicing: Required
Electronic ordering will be used: no
Electronic payment will be used: no
5.1.16.
Further information, mediation and review
Review organisation: Órgano Administrativo de Recursos Contractuales de la Comunidad Autónoma de Euskadi
Information about review deadlines: Se iniciará mediante escrito que deberá presentarse en el plazo de 15 días hábiles. Dicho plazo se computará conforme a la Ley de Contratos del Sector Público.
Organisation providing additional information about the procurement procedure: OSAKIDETZA - Servicio Vasco de Salud - Organización Central
5.1.
Lot: LOT-0003
Title: 3 - CARMUSTINA (DOE) PARENTENAL
Description: CARMUSTINA (DOE) PARENTENAL
Internal identifier: 3 - CARMUSTINA (DOE) PARENTENAL
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33600000 Pharmaceutical products
5.1.2.
Place of performance
Country subdivision (NUTS): Araba/Álava (ES211)
5.1.2.
Place of performance
Country subdivision (NUTS): Gipuzkoa (ES212)
5.1.2.
Place of performance
Country subdivision (NUTS): Bizkaia (ES213)
5.1.3.
Estimated duration
Duration: 1 Year
5.1.4.
Renewal
Maximum renewals: 0
5.1.6.
General information
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): yes
5.1.12.
Terms of procurement
Terms of contract: 
The execution of the contract must be performed within the framework of sheltered employment programmes: No
Electronic invoicing: Required
Electronic ordering will be used: no
Electronic payment will be used: no
5.1.16.
Further information, mediation and review
Review organisation: Órgano Administrativo de Recursos Contractuales de la Comunidad Autónoma de Euskadi
Information about review deadlines: Se iniciará mediante escrito que deberá presentarse en el plazo de 15 días hábiles. Dicho plazo se computará conforme a la Ley de Contratos del Sector Público.
Organisation providing additional information about the procurement procedure: OSAKIDETZA - Servicio Vasco de Salud - Organización Central
5.1.
Lot: LOT-0004
Title: 4 - DEFERASIROX (DOE)
Description: DEFERASIROX (DOE)
Internal identifier: 4 - DEFERASIROX (DOE)
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33600000 Pharmaceutical products
5.1.2.
Place of performance
Country subdivision (NUTS): Araba/Álava (ES211)
5.1.2.
Place of performance
Country subdivision (NUTS): Gipuzkoa (ES212)
5.1.2.
Place of performance
Country subdivision (NUTS): Bizkaia (ES213)
5.1.3.
Estimated duration
Duration: 1 Year
5.1.4.
Renewal
Maximum renewals: 0
5.1.6.
General information
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): yes
5.1.12.
Terms of procurement
Terms of contract: 
The execution of the contract must be performed within the framework of sheltered employment programmes: No
Electronic invoicing: Required
Electronic ordering will be used: no
Electronic payment will be used: no
5.1.16.
Further information, mediation and review
Review organisation: Órgano Administrativo de Recursos Contractuales de la Comunidad Autónoma de Euskadi
Information about review deadlines: Se iniciará mediante escrito que deberá presentarse en el plazo de 15 días hábiles. Dicho plazo se computará conforme a la Ley de Contratos del Sector Público.
Organisation providing additional information about the procurement procedure: OSAKIDETZA - Servicio Vasco de Salud - Organización Central
5.1.
Lot: LOT-0005
Title: 5 - AMOXICILINA/ÁCIDO CLAVULÁNICO (DOE) PARENTERAL
Description: AMOXICILINA/ÁCIDO CLAVULÁNICO (DOE) PARENTERAL
Internal identifier: 5 - AMOXICILINA/ÁCIDO CLAVULÁNICO (DOE) PARENTERAL
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33600000 Pharmaceutical products
5.1.2.
Place of performance
Country subdivision (NUTS): Araba/Álava (ES211)
5.1.2.
Place of performance
Country subdivision (NUTS): Gipuzkoa (ES212)
5.1.2.
Place of performance
Country subdivision (NUTS): Bizkaia (ES213)
5.1.3.
Estimated duration
Duration: 1 Year
5.1.4.
Renewal
Maximum renewals: 0
5.1.6.
General information
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): yes
5.1.12.
Terms of procurement
Terms of contract: 
The execution of the contract must be performed within the framework of sheltered employment programmes: No
Electronic invoicing: Required
Electronic ordering will be used: no
Electronic payment will be used: no
5.1.16.
Further information, mediation and review
Review organisation: Órgano Administrativo de Recursos Contractuales de la Comunidad Autónoma de Euskadi
Information about review deadlines: Se iniciará mediante escrito que deberá presentarse en el plazo de 15 días hábiles. Dicho plazo se computará conforme a la Ley de Contratos del Sector Público.
Organisation providing additional information about the procurement procedure: OSAKIDETZA - Servicio Vasco de Salud - Organización Central
5.1.
Lot: LOT-0006
Title: 6 - ASOCIACIÓN FORMOTEROL/BUDESONIDA (DOE) POLVO PARA INHALACION
Description: ASOCIACIÓN FORMOTEROL/BUDESONIDA (DOE) POLVO PARA INHALACION
Internal identifier: 6 - ASOCIACIÓN FORMOTEROL/BUDESONIDA (DOE) POLVO PARA INHALACION
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33600000 Pharmaceutical products
5.1.2.
Place of performance
Country subdivision (NUTS): Araba/Álava (ES211)
5.1.2.
Place of performance
Country subdivision (NUTS): Gipuzkoa (ES212)
5.1.2.
Place of performance
Country subdivision (NUTS): Bizkaia (ES213)
5.1.3.
Estimated duration
Duration: 1 Year
5.1.4.
Renewal
Maximum renewals: 0
5.1.6.
General information
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): yes
5.1.12.
Terms of procurement
Terms of contract: 
The execution of the contract must be performed within the framework of sheltered employment programmes: No
Electronic invoicing: Required
Electronic ordering will be used: no
Electronic payment will be used: no
5.1.16.
Further information, mediation and review
Review organisation: Órgano Administrativo de Recursos Contractuales de la Comunidad Autónoma de Euskadi
Information about review deadlines: Se iniciará mediante escrito que deberá presentarse en el plazo de 15 días hábiles. Dicho plazo se computará conforme a la Ley de Contratos del Sector Público.
Organisation providing additional information about the procurement procedure: OSAKIDETZA - Servicio Vasco de Salud - Organización Central
5.1.
Lot: LOT-0007
Title: 7 - ASOCIACIÓN FORMOTEROL/BUDESONIDA (DOE) SUSPENSION PARA INHALACION
Description: ASOCIACIÓN FORMOTEROL/BUDESONIDA (DOE) SUSPENSION PARA INHALACION
Internal identifier: 7 - ASOCIACIÓN FORMOTEROL/BUDESONIDA (DOE) SUSPENSION PARA INHALACION
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33600000 Pharmaceutical products
5.1.2.
Place of performance
Country subdivision (NUTS): Araba/Álava (ES211)
5.1.2.
Place of performance
Country subdivision (NUTS): Gipuzkoa (ES212)
5.1.2.
Place of performance
Country subdivision (NUTS): Bizkaia (ES213)
5.1.3.
Estimated duration
Duration: 1 Year
5.1.4.
Renewal
Maximum renewals: 0
5.1.6.
General information
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): yes
5.1.12.
Terms of procurement
Terms of contract: 
The execution of the contract must be performed within the framework of sheltered employment programmes: No
Electronic invoicing: Required
Electronic ordering will be used: no
Electronic payment will be used: no
5.1.16.
Further information, mediation and review
Review organisation: Órgano Administrativo de Recursos Contractuales de la Comunidad Autónoma de Euskadi
Information about review deadlines: Se iniciará mediante escrito que deberá presentarse en el plazo de 15 días hábiles. Dicho plazo se computará conforme a la Ley de Contratos del Sector Público.
Organisation providing additional information about the procurement procedure: OSAKIDETZA - Servicio Vasco de Salud - Organización Central
6. Results
Value of all contracts awarded in this notice: 549 526,50 EUR
6.1.
Result lot identifier: LOT-0001
6.1.2.
Information about winners
Winner: 
Official name: LABORATORIO REIG JOFRÉ S.A.
Tender: 
Tender identifier: 1270109
Identifier of lot or group of lots: LOT-0001
Value of the tender: 6 000,00 EUR
Subcontracting: No
Contract information: 
Identifier of the contract: 2022/01932252_00001
Title: Suministro Gefitinib(DOE), Tenofovir disoproxilo (DOE), Carmustina (DOE) Parenteral, Deferasirox(DOE), Amoxicilina/Ácido Clavulánico (DOE) Parenteral y Asociacion Formoterol/Budesonida (DOE)
Date of the conclusion of the contract: 01/02/2023
6.1.
Result lot identifier: LOT-0002
6.1.2.
Information about winners
Winner: 
Official name: MACLEODS PHARMA ESPAÑA SL
Tender: 
Tender identifier: 1270110
Identifier of lot or group of lots: LOT-0002
Value of the tender: 47 500,00 EUR
Subcontracting: No
Contract information: 
Identifier of the contract: 2022/01932252_00002
Title: Suministro Gefitinib(DOE), Tenofovir disoproxilo (DOE), Carmustina (DOE) Parenteral, Deferasirox(DOE), Amoxicilina/Ácido Clavulánico (DOE) Parenteral y Asociacion Formoterol/Budesonida (DOE)
Date of the conclusion of the contract: 01/02/2023
6.1.
Result lot identifier: LOT-0003
6.1.2.
Information about winners
Winner: 
Official name: TEVA PHARMA, S.L.
Tender: 
Tender identifier: 1270111
Identifier of lot or group of lots: LOT-0003
Value of the tender: 87 000,00 EUR
Subcontracting: No
Contract information: 
Identifier of the contract: 2022/01932252_00003
Title: Suministro Gefitinib(DOE), Tenofovir disoproxilo (DOE), Carmustina (DOE) Parenteral, Deferasirox(DOE), Amoxicilina/Ácido Clavulánico (DOE) Parenteral y Asociacion Formoterol/Budesonida (DOE)
Date of the conclusion of the contract: 01/02/2023
6.1.
Result lot identifier: LOT-0004
6.1.2.
Information about winners
Winner: 
Official name: VISO FARMACEUTICA SL
Tender: 
Tender identifier: 1270112
Identifier of lot or group of lots: LOT-0004
Value of the tender: 36 825,00 EUR
Subcontracting: No
Contract information: 
Identifier of the contract: 2022/01932252_00004
Title: Suministro Gefitinib(DOE), Tenofovir disoproxilo (DOE), Carmustina (DOE) Parenteral, Deferasirox(DOE), Amoxicilina/Ácido Clavulánico (DOE) Parenteral y Asociacion Formoterol/Budesonida (DOE)
Date of the conclusion of the contract: 01/02/2023
6.1.
Result lot identifier: LOT-0005
6.1.2.
Information about winners
Winner: 
Official name: SANDOZ FARMACEUTICA S A
Tender: 
Tender identifier: 1270113
Identifier of lot or group of lots: LOT-0005
Value of the tender: 369 900,00 EUR
Subcontracting: No
Contract information: 
Identifier of the contract: 2022/01932252_00005
Title: Suministro Gefitinib(DOE), Tenofovir disoproxilo (DOE), Carmustina (DOE) Parenteral, Deferasirox(DOE), Amoxicilina/Ácido Clavulánico (DOE) Parenteral y Asociacion Formoterol/Budesonida (DOE)
Date of the conclusion of the contract: 01/02/2023
6.1.
Result lot identifier: LOT-0006
6.1.2.
Information about winners
Winner: 
Official name: TEVA PHARMA, S.L.
Tender: 
Tender identifier: 1270114
Identifier of lot or group of lots: LOT-0006
Value of the tender: 24,50 EUR
Subcontracting: No
Contract information: 
Identifier of the contract: 2022/01932252_00006
Title: Suministro Gefitinib(DOE), Tenofovir disoproxilo (DOE), Carmustina (DOE) Parenteral, Deferasirox(DOE), Amoxicilina/Ácido Clavulánico (DOE) Parenteral y Asociacion Formoterol/Budesonida (DOE)
Date of the conclusion of the contract: 01/02/2023
6.1.
Result lot identifier: LOT-0007
6.1.2.
Information about winners
Winner: 
Official name: ASTRAZENECA FARMACEUTICA SPAIN, S.A.
Tender: 
Tender identifier: 1270115
Identifier of lot or group of lots: LOT-0007
Value of the tender: 2 277,00 EUR
Subcontracting: No
Contract information: 
Identifier of the contract: 2022/01932252_00007
Title: Suministro Gefitinib(DOE), Tenofovir disoproxilo (DOE), Carmustina (DOE) Parenteral, Deferasirox(DOE), Amoxicilina/Ácido Clavulánico (DOE) Parenteral y Asociacion Formoterol/Budesonida (DOE)
Date of the conclusion of the contract: 01/02/2023
7. Modification
7.1.
Modification
Identifier of the previous contract award notice: 077873-2023
Reason for modification: Modifications based on review clauses or options.
Description: Prórroga 1: Importe de la prórroga: 49400. Incremento del plazo: 12. Fecha Acuerdo: 2024-01-17+01:00. Fecha finalización: 2025-02-01+01:00. Prórroga 2: Importe de la prórroga: 49400. Incremento del plazo: 12. Fecha Acuerdo: 2025-01-22+01:00. Fecha finalización: 2026-02-01+01:00.
7.1.1.
Change
Description of modifications: Prórroga
Section identifier: CON-0002
7.1.
Modification
Identifier of the previous contract award notice: 077873-2023
Reason for modification: Modifications based on review clauses or options.
Description: Prórroga 1: Importe de la prórroga: 90480. Incremento del plazo: 12. Fecha Acuerdo: 2024-01-17+01:00. Fecha finalización: 2025-02-01+01:00. Prórroga 2: Importe de la prórroga: 90480. Incremento del plazo: 12. Fecha Acuerdo: 2025-01-22+01:00. Fecha finalización: 2026-02-01+01:00.
7.1.1.
Change
Description of modifications: Prórroga
Section identifier: CON-0003
7.1.
Modification
Identifier of the previous contract award notice: 077873-2023
Reason for modification: Modifications based on review clauses or options.
Description: Prórroga 1: Importe de la prórroga: 38298. Incremento del plazo: 12. Fecha Acuerdo: 2024-01-17+01:00. Fecha finalización: 2025-02-01+01:00. Prórroga 2: Importe de la prórroga: 38298. Incremento del plazo: 12. Fecha Acuerdo: 2025-01-22+01:00. Fecha finalización: 2026-02-01+01:00.
7.1.1.
Change
Description of modifications: Prórroga
Section identifier: CON-0004
7.1.
Modification
Identifier of the previous contract award notice: 077873-2023
Reason for modification: Modifications based on review clauses or options.
Description: Prórroga 1: Importe de la prórroga: 384696. Incremento del plazo: 12. Fecha Acuerdo: 2024-01-17+01:00. Fecha finalización: 2025-02-01+01:00. Prórroga 2: Importe de la prórroga: 384696. Incremento del plazo: 12. Fecha Acuerdo: 2025-01-22+01:00. Fecha finalización: 2026-02-01+01:00.
7.1.1.
Change
Description of modifications: Prórroga
Section identifier: CON-0005
7.1.
Modification
Identifier of the previous contract award notice: 077873-2023
Reason for modification: Modifications based on review clauses or options.
Description: Prórroga 1: Importe de la prórroga: 25.48. Incremento del plazo: 12. Fecha Acuerdo: 2024-01-17+01:00. Fecha finalización: 2025-02-01+01:00. Prórroga 2: Importe de la prórroga: 25.48. Incremento del plazo: 12. Fecha Acuerdo: 2025-01-22+01:00. Fecha finalización: 2026-02-01+01:00.
7.1.1.
Change
Description of modifications: Prórroga
Section identifier: CON-0006
7.1.
Modification
Identifier of the previous contract award notice: 077873-2023
Reason for modification: Modifications based on review clauses or options.
Description: Prórroga 1: Importe de la prórroga: 2368.08. Incremento del plazo: 12. Fecha Acuerdo: 2024-01-17+01:00. Fecha finalización: 2025-02-01+01:00. Prórroga 2: Importe de la prórroga: 2368.08. Incremento del plazo: 12. Fecha Acuerdo: 2025-01-22+01:00. Fecha finalización: 2026-02-01+01:00.
7.1.1.
Change
Description of modifications: Prórroga
Section identifier: CON-0007
8. Organisations
8.1.
ORG-0001
Official name: Órgano Administrativo de Recursos Contractuales de la Comunidad Autónoma de Euskadi
Registration number: 71487.0
Postal address: C/ Donostia-San Sebastián, 1
Town: Vitoria-Gasteiz
Postcode: 01010
Country: Spain
Email: oarc@euskadi.eus
Telephone: +34 945018000
Internet address: http://www.ejgv.euskadi.eus
Roles of this organisation: 
Review organisation
8.1.
ORG-0003
Official name: OSAKIDETZA - Servicio Vasco de Salud - Organización Central
Registration number: S5100023J
Postal address: Alava, 45
Town: Vitoria-Gasteiz
Postcode: 01006
Country: Spain
Contact point: Servicio de Farmacia
Email: contrata@osakidetza.eus
Telephone: +34 945207951
Internet address: http://www.osakidetza.euskadi.net
Roles of this organisation: 
Buyer
Organisation providing additional information about the procurement procedure
8.1.
ORG-0005
Official name: LABORATORIO REIG JOFRÉ S.A.
Registration number: A96184882
Postal address: AV GRAN CAPITA 10
Town: Sant Joan Despí
Postcode: 08970
Country: Spain
Email: paloma.martin@reigjofre.com
Telephone: +34 914153801
Fax: +34 915191849
Roles of this organisation: 
Tenderer
Winner of these lots: LOT-0001
8.1.
ORG-0006
Official name: MACLEODS PHARMA ESPAÑA SL
Registration number: B66628355
Postal address: Avenida Diagonal 409 1ª Planta
Town: Barcelona
Postcode: 08008
Country: Spain
Email: macleodsespana@macleodspharma.com
Telephone: +34 606289091
Roles of this organisation: 
Tenderer
Winner of these lots: LOT-0002
8.1.
ORG-0007
Official name: TEVA PHARMA, S.L.
Registration number: B83959379
Postal address: CALLE ANABEL SEGURA 11
Town: Alcobendas
Postcode: 28108
Country: Spain
Email: rocio.santafe@tevaes.com
Telephone: +34 913542648
Roles of this organisation: 
Tenderer
Winner of these lots: LOT-0003, LOT-0006
8.1.
ORG-0008
Official name: VISO FARMACEUTICA SL
Registration number: B87283438
Postal address: Calle Retama nº7, 7ªPlanta
Town: Madrid
Postcode: 28045
Country: Spain
Email: viso@dptolicitaciones.com
Telephone: +34 911593944
Roles of this organisation: 
Tenderer
Winner of these lots: LOT-0004
8.1.
ORG-0009
Official name: SANDOZ FARMACEUTICA S A
Registration number: A08233801
Postal address: Serrano Galvache
Town: Madrid
Postcode: 28033
Country: Spain
Email: sandoz.concursos@sandoz.com
Telephone: +34 662170423
Roles of this organisation: 
Tenderer
Winner of these lots: LOT-0005
8.1.
ORG-0011
Official name: ASTRAZENECA FARMACEUTICA SPAIN, S.A.
Registration number: A36002129
Postal address: Calle de Serrano Galvache, 56, 28033 Madrid, España
Town: Bustarviejo
Postcode: 28079
Country: Spain
Email: ofertasconcursos@astrazeneca.com
Telephone: +34 900200444
Roles of this organisation: 
Tenderer
Winner of these lots: LOT-0007
Notice information
Notice identifier/version: 8ec36505-c7cd-4efb-a31f-815d48031b85  -  01
Form type: Contract modification
Notice type: Contract modification notice
Notice subtype: 38
Notice dispatch date: 03/02/2025 09:45:04 (UTC+01:00) Central European Time, Western European Summer Time
Languages in which this notice is officially available: Spanish
Notice publication number: 75701-2025
OJ S issue number: 24/2025
Publication date: 04/02/2025